DE60141680D1 - Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln - Google Patents

Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln

Info

Publication number
DE60141680D1
DE60141680D1 DE60141680T DE60141680T DE60141680D1 DE 60141680 D1 DE60141680 D1 DE 60141680D1 DE 60141680 T DE60141680 T DE 60141680T DE 60141680 T DE60141680 T DE 60141680T DE 60141680 D1 DE60141680 D1 DE 60141680D1
Authority
DE
Germany
Prior art keywords
agent
particles
mixture
drug
macromolecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60141680T
Other languages
German (de)
English (en)
Inventor
Edith Mathiowitz
Yong S Jong
Jules Jacob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brown University Research Foundation Inc
Original Assignee
Brown University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brown University Research Foundation Inc filed Critical Brown University Research Foundation Inc
Application granted granted Critical
Publication of DE60141680D1 publication Critical patent/DE60141680D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60141680T 2000-01-14 2001-01-12 Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln Expired - Lifetime DE60141680D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17619300P 2000-01-14 2000-01-14
PCT/US2001/001183 WO2001051032A2 (en) 2000-01-14 2001-01-12 Micronized freeze-dried particles

Publications (1)

Publication Number Publication Date
DE60141680D1 true DE60141680D1 (de) 2010-05-12

Family

ID=22643372

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60141680T Expired - Lifetime DE60141680D1 (de) 2000-01-14 2001-01-12 Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln

Country Status (7)

Country Link
EP (1) EP1246609B1 (https=)
JP (1) JP2003519651A (https=)
AT (1) ATE462413T1 (https=)
AU (1) AU773735B2 (https=)
CA (1) CA2397404C (https=)
DE (1) DE60141680D1 (https=)
WO (1) WO2001051032A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809309B1 (fr) * 2000-05-23 2004-06-11 Mainelab Microspheres a liberation prolongee pour administration injectable
EP1423175B1 (en) 2001-08-08 2013-10-02 Brown University Research Foundation Methods for micronization of hydrophobic drugs
CA2469718A1 (en) * 2001-12-10 2003-06-19 Spherics, Inc. Methods and products useful in the formation and isolation of microparticles
US20050152980A1 (en) 2002-03-13 2005-07-14 Michael Ausborn Pharmeutical microparticles
SI21222A (sl) * 2002-05-28 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo nanodelcev
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
JP2006199589A (ja) * 2003-09-03 2006-08-03 Ltt Bio-Pharma Co Ltd 生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤
WO2006088647A1 (en) * 2005-02-17 2006-08-24 Medivas, Llc Polymer particle delivery compositions and methods of use
CN1894026B (zh) * 2003-12-19 2012-01-25 阿尔克-阿贝洛有限公司 用于活性药剂的低温制粒和贮藏的方法
EP1697033B1 (en) 2003-12-19 2011-04-13 Alk-Abelló A/S Process for cryogranulation and storage of allergens
CA2623239C (en) 2005-09-22 2016-07-12 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
CN101410098B (zh) * 2006-01-23 2012-01-18 耶路撒冷希伯来大学伊森姆研究发展公司 包括含亲脂性药物的纳米胶囊的微球
JP6910949B2 (ja) * 2014-08-14 2021-07-28 ブラウン ユニバーシティ タンパク質を安定化させ、送達するための組成物
CN108379243A (zh) * 2018-03-22 2018-08-10 福州大学 一种载基因多孔磁性微球的制备方法
CN115005320B (zh) * 2022-05-07 2023-09-05 中国农业大学 一种具有长效饱腹感的酪蛋白粉的制备方法及所得产物
CN116982619A (zh) * 2023-08-04 2023-11-03 洛阳奇泓生物科技有限公司 丙交酯-Nisin固体分散体及其制备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU587299B2 (en) * 1985-11-27 1989-08-10 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug
ES2032831T5 (es) * 1986-08-19 2001-02-16 Genentech Inc Dispositivo y dispersion para suministro intrapulmonar de factores de crecimiento polipeptidos y citoquinas.
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
EP0840623B1 (en) * 1995-07-21 2007-07-18 Brown University Research Foundation Compositions for gene therapy comprising nucleic acid loaded polymeric microparticles
DE69717263T2 (de) * 1996-03-28 2003-07-24 Takeda Chemical Industries, Ltd. Zubereitung mit verzögerter freisetzung und deren herstellung
AU7134898A (en) * 1997-04-17 1998-11-11 Amgen, Inc. Biodegradable microparticles for the sustained delivery of therapeutic drugs
JP3918248B2 (ja) * 1997-09-26 2007-05-23 ソニー株式会社 固体撮像素子およびその駆動方法

Also Published As

Publication number Publication date
CA2397404C (en) 2008-12-02
ATE462413T1 (de) 2010-04-15
AU773735B2 (en) 2004-06-03
EP1246609A2 (en) 2002-10-09
AU2790201A (en) 2001-07-24
JP2003519651A (ja) 2003-06-24
WO2001051032A2 (en) 2001-07-19
WO2001051032A3 (en) 2002-03-28
CA2397404A1 (en) 2001-07-19
EP1246609B1 (en) 2010-03-31

Similar Documents

Publication Publication Date Title
DE60141680D1 (de) Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln
Gómez-Mascaraque et al. Electrosprayed gelatin submicroparticles as edible carriers for the encapsulation of polyphenols of interest in functional foods
Rill et al. Properties of nuclease-resistant fragments of calf thymus chromatin
GR3018939T3 (en) Method for producing protein microspheres
Kim et al. Microencapsulation of dissociable human growth hormone aggregates within poly (D, L-lactic-co-glycolic acid) microparticles for sustained release
NO20000913L (no) Sfæriske mikropartikler inneholdende lineære polysakkarider
DE59607548D1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln
ATE277601T1 (de) Verbesserungen bezüglich der verkapselung bioaktiver wirkstoffe
EP0102265A3 (en) Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
EP0625069A1 (de) Verfahren zur herstellung von mikrokapseln
JP5373618B2 (ja) 微粒化方法
DE60030999D1 (de) Verfahren zur herstellung von teilchen
DE502006005846D1 (de) Verfahren zur schonenden herstellung hochfeiner partikelsuspensionen und hochfeiner partikel sowie deren verwendung
DE60209516D1 (de) Prozess zur Herstellung kristalliner Partikel von Fluticason, Beclomethason, Salmeterol und Salbutamol
Yang et al. Phenyl groups in supramolecular nanofibers confer hydrogels with high elasticity and rapid recovery
RU2000113730A (ru) Гранулы на полиэтиленгликолевой матрице для жирных, маслянистых или клейких лекарственных веществ
JP2017522394A5 (https=)
IE58245B1 (en) Micro-encapsulation of medicaments
JP2009513165A5 (https=)
CY1113221T1 (el) Διεργασια για την παρασκευη ενος φαρμακου
DE4309168A1 (de) Pulverförmiges Ausgangsmaterial für die Herstellung einer Arzneimittel-Beschichtungslösung
CN116803382B (zh) 一种曲安奈德缓释微球、制备方法及曲安奈德缓释制剂
Symecko et al. Binder functionality in tabletted systems
TW200502039A (en) Process for the preparation of catalyst microspheres
HK1049113A1 (zh) 含新红血球生成的刺激性蛋白质的生物所能分解的微粒子

Legal Events

Date Code Title Description
8364 No opposition during term of opposition